tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PolyPid Reports Positive Phase 3 Results and Strengthens Leadership
PremiumCompany AnnouncementsPolyPid Reports Positive Phase 3 Results and Strengthens Leadership
2d ago
PolyPid reports Q2 EPS (78c), consensus (55c)
Premium
The Fly
PolyPid reports Q2 EPS (78c), consensus (55c)
2d ago
PolyPid sees cash runway ‘well into’ 2026
Premium
The Fly
PolyPid sees cash runway ‘well into’ 2026
2d ago
PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
PremiumCompany AnnouncementsPolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
1M ago
PolyPid Approves Key Resolutions at Annual Shareholder Meeting
Premium
Company Announcements
PolyPid Approves Key Resolutions at Annual Shareholder Meeting
2M ago
Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks
Premium
Stock Analysis & Ideas
Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks
2M ago
PolyPid price target raised to $13 from $11 at H.C. Wainwright
PremiumThe FlyPolyPid price target raised to $13 from $11 at H.C. Wainwright
2M ago
PolyPid’s D-PLEX100: Compelling Phase 3 Results and Strong Commercial Prospects Justify Buy Rating
Premium
Ratings
PolyPid’s D-PLEX100: Compelling Phase 3 Results and Strong Commercial Prospects Justify Buy Rating
2M ago
PolyPid’s D-PLEX100 Achieves Positive Phase 3 Results in SHIELD II Trial
Premium
Company Announcements
PolyPid’s D-PLEX100 Achieves Positive Phase 3 Results in SHIELD II Trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100